About Prevtec Microbia
Prevtec Microbia is a company based in Montreal (Canada) founded in 2003 was acquired by Elanco in August 2019. Prevtec Microbia has raised $12.41 million across 4 funding rounds from investors including Elanco, Victor Valley College and Telesystem.
- Headquarter Montreal, Canada
-
Sectors
Agriculture
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Prevtec Microbia
Prevtec Microbia has successfully raised a total of $12.41M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $1.87 million completed in March 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Prevtec Microbia
Prevtec Microbia has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Elanco, Victor Valley College and Telesystem.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Telesystem is engaged in investment and innovation across sectors.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Canadian tech and energy companies are invested in by Desjardins-Innovatech.
|
Locked | Locked | Locked |
Investor details for Prevtec Microbia
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Prevtec Microbia
Investment portfolio details for Prevtec Microbia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Prevtec Microbia
Detailed financials for Prevtec Microbia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Prevtec Microbia Comparisons
Peer comparison for Prevtec Microbia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Prevtec Microbia
Detailed competitors of Prevtec Microbia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Prevtec Microbia
Complete news archive for Prevtec Microbia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prevtec Microbia
Prevtec Microbia was founded in 2003 and raised its 1st funding round 8 years after it was founded.
Prevtec Microbia is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
Prevtec Microbia is a funded company, having raised a total of $12.41M across 4 funding rounds to date.
Prevtec Microbia was founded in 2003 in Montreal, Canada, and operates in the biotechnology sector. Focus is placed on the development and marketing of vaccines for livestock animals, including the flagship product ColiProtec F4, which targets postweaning diarrhea in swine caused by enterotoxigenic Escherichia coli with F4 attachment factor. This vaccine is noted as the only one licensed in the European Union for active immunization against the condition.
Prevtec Microbia has 9 investors. Key investors include Elanco, Victor Valley College, Telesystem, Echo Capital, and Grupo Fuertes.